LMAT

82.91

2.75% 2.22

Dopo l'orario di chiusura: 82.91

Lemaitre Vascular Inc (LMAT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

$80.69

Aprire:

$80.77

Volume 24 ore:

257.86K

Relative Volume:

0.99

Capitalizzazione di mercato:

$1.90B

Reddito:

$256.28M

Utile/perdita netta:

$62.40M

Rapporto P/E:

30.55

EPS:

2.7139

Flusso di cassa netto:

$79.12M

1 W Prestazione:

+2.37%

1M Prestazione:

+2.88%

6M Prestazione:

-27.67%

1 anno Prestazione:

-3.65%

Intervallo 1D:

$80.03

$83.25

Intervallo di 1 settimana:

$78.31

$83.25

Portata 52W:

$78.22

$118.01

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Nome

Lemaitre Vascular Inc

Settore

Healthcare (1051)

Industria

Medical Instruments & Supplies (50)

Telefono

781-221-2266

Indirizzo

63 SECOND AVENUE, BURLINGTON, MA

Dipendente

655

Cinguettio

@LMAT_Vascular

Prossima data di guadagno

2026-11-05

Ultimi documenti SEC

LMAT's Discussions on Twitter

Compare LMAT vs ISRG, BDX, RMD, MDLN, ALC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LMAT Lemaitre Vascular Inc	82.91	1.90B	256.28M	62.40M	79.12M	2.7139
ISRG Intuitive Surgical Inc	427.64	151.08B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	188.89	51.45B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	234.60	32.99B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.76	31.37B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	64.35	31.11B	10.63B	819.00M	1.59B	1.6577

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-08-05	Downgrade	Barrington Research	Outperform → Mkt Perform
2025-08-06	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2025-02-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2025-02-28	Downgrade	Oppenheimer	Outperform → Perform
2025-02-13	Iniziato	Wells Fargo	Equal Weight
2024-10-15	Iniziato	Cantor Fitzgerald	Neutral
2024-08-02	Ripresa	Lake Street	Buy
2024-05-31	Ripresa	ROTH MKM	Buy
2024-04-26	Aggiornamento	Stifel	Hold → Buy
2024-02-06	Ripresa	KeyBanc Capital Markets	Sector Weight
2023-10-23	Iniziato	JMP Securities	Mkt Outperform
2023-09-06	Iniziato	Oppenheimer	Outperform
2023-08-03	Downgrade	Jefferies	Buy → Hold
2023-05-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-10-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2021-09-16	Iniziato	Jefferies	Buy
2021-02-12	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-03-16	Aggiornamento	Sidoti	Neutral → Buy
2019-10-24	Downgrade	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Aggiornamento	Lake Street	Hold → Buy
2019-10-14	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Reiterato	Barrington Research	Outperform
2019-07-25	Aggiornamento	First Analysis Sec	Neutral → Outperform
2018-10-08	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2018-10-08	Aggiornamento	ROTH Capital	Neutral → Buy
2018-06-08	Ripresa	ROTH Capital	Buy
2018-04-26	Downgrade	Stifel	Buy → Hold
2018-04-26	Aggiornamento	The Benchmark Company	Hold → Buy
2017-10-27	Downgrade	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Downgrade	The Benchmark Company	Buy → Hold
2017-07-10	Downgrade	Canaccord Genuity	Buy → Hold
2017-07-10	Downgrade	The Benchmark Company	Buy → Hold
2017-03-21	Iniziato	First Analysis Sec	Overweight
2017-02-22	Downgrade	Barrington Research	Outperform → Mkt Perform
2016-09-22	Downgrade	Sidoti	Buy → Neutral
2016-07-28	Reiterato	Barrington Research	Outperform
2016-02-25	Reiterato	Barrington Research	Outperform

Mostra tutto

Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie

04:49 AM

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026 - GlobeNewswire

04:49 AM

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026 - GlobeNewswire Inc.

04:49 AM

Oct 11, 2026

LeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition Machine (NASDAQ:LMAT) - Seeking Alpha

Oct 01, 2026

Sep 30, 2026